Page last updated: 2024-08-17

bromodeoxyuridine and oblimersen

bromodeoxyuridine has been researched along with oblimersen in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benimetskaya, L; Lai, JC; Miller, PS; Santella, RM; Stein, CA; Wang, Q1

Other Studies

1 other study(ies) available for bromodeoxyuridine and oblimersen

ArticleYear
G3139 (oblimersen) may inhibit prostate cancer cell growth in a partially bis-CpG-dependent non-antisense manner.
    Molecular cancer therapeutics, 2003, Volume: 2, Issue:10

    Topics: Agar; Amino Acid Motifs; Annexin A5; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Membrane; Coloring Agents; CpG Islands; DNA; DNA Methylation; Down-Regulation; Enzyme Inhibitors; Flow Cytometry; G1 Phase; Guanosine; Humans; Male; Membrane Potentials; Mitochondria; Mutation; Oligonucleotides; Oligonucleotides, Antisense; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Reactive Oxygen Species; S Phase; Thionucleotides; Time Factors; Transfection

2003